Venrock Healthcare Capital Partners II, L.P. - Significant Ownership

Signature - Title
/s/ Sherman G. Souther - By VHCP Management II, LLC, its General Partner, By Sherman G. Souther, Authorized Signatory
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Venrock Healthcare Capital Partners II, L.P..

Significant Ownership of Venrock Healthcare Capital Partners II, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
DBVT DBV TECHNOLOGIES S.A. Ordinary Shares, nominal value 0.01 euro per share 8.2% $119M -$23.6M 11.9M -16.5% Venrock Healthcare Capital Partners II, L.P. Sep 30, 2025
COGT Cogent Biosciences, Inc. Common Stock, $0.001 par value per share 4.2% $57.4M -$20.4M 4.76M -26.2% Venrock Healthcare Capital Partners II, L.P. Jun 30, 2025
TRVI Trevi Therapeutics, Inc. Common Stock, $0.001 par value 1.4% $7.66M 1.27M Venrock Healthcare Capital Partners II, L.P. Dec 31, 2024

Schedules 13D/G Reported by Venrock Healthcare Capital Partners II, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.